Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · Real-Time Price · USD
4.330
0.00 (0.00%)
Nov 21, 2024, 4:00 PM EST - Market closed
Lumos Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 13.52 | 35.08 | 56.01 | 94.81 | 98.68 | 4.95 | Upgrade
|
| Short-Term Investments | - | 1 | 11.35 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 13.52 | 36.08 | 67.36 | 94.81 | 98.68 | 4.95 | Upgrade
|
| Cash Growth | -68.34% | -46.44% | -28.95% | -3.92% | 1892.71% | -64.68% | Upgrade
|
| Other Receivables | 0.17 | 0.21 | 0.22 | 0.13 | 26.26 | 0.04 | Upgrade
|
| Receivables | 0.17 | 0.21 | 0.22 | 0.13 | 26.26 | 0.04 | Upgrade
|
| Prepaid Expenses | 3.58 | 3.75 | 4.43 | 4.74 | 3.51 | 0.08 | Upgrade
|
| Total Current Assets | 17.27 | 40.04 | 72.01 | 99.68 | 128.45 | 5.07 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.6 | 0.28 | 0.64 | 0.58 | 0.46 | Upgrade
|
| Total Assets | 17.46 | 40.64 | 72.29 | 100.31 | 129.03 | 5.53 | Upgrade
|
| Accounts Payable | 1.46 | 0.89 | 0.28 | 0.61 | 0.24 | 0.37 | Upgrade
|
| Accrued Expenses | 4.92 | 5.86 | 6.2 | 4.17 | 5.2 | 0.71 | Upgrade
|
| Current Portion of Leases | 0.13 | 0.28 | 0.23 | 0.35 | 0.32 | 0.19 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.7 | - | Upgrade
|
| Total Current Liabilities | 6.51 | 7.03 | 6.71 | 5.13 | 6.46 | 1.26 | Upgrade
|
| Long-Term Leases | 0.04 | 0.3 | - | 0.21 | - | 0.19 | Upgrade
|
| Other Long-Term Liabilities | 6 | 6 | 6 | 6 | 6 | - | Upgrade
|
| Total Liabilities | 12.55 | 13.33 | 12.71 | 11.34 | 12.46 | 1.45 | Upgrade
|
| Common Stock | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 192.02 | 188.94 | 187.16 | 185.43 | 182.48 | 0.2 | Upgrade
|
| Retained Earnings | -186.98 | -161.52 | -127.48 | -96.42 | -65.99 | -59.68 | Upgrade
|
| Treasury Stock | -0.22 | -0.2 | -0.17 | -0.11 | - | - | Upgrade
|
| Comprehensive Income & Other | - | - | -0.01 | - | - | - | Upgrade
|
| Total Common Equity | 4.91 | 27.31 | 59.58 | 88.98 | 116.57 | -59.46 | Upgrade
|
| Shareholders' Equity | 4.91 | 27.31 | 59.58 | 88.98 | 116.57 | 4.07 | Upgrade
|
| Total Liabilities & Equity | 17.46 | 40.64 | 72.29 | 100.31 | 129.03 | 5.53 | Upgrade
|
| Total Debt | 0.17 | 0.59 | 0.23 | 0.56 | 0.32 | 0.38 | Upgrade
|
| Net Cash (Debt) | 13.35 | 35.49 | 67.13 | 94.25 | 98.36 | 4.57 | Upgrade
|
| Net Cash Growth | -68.54% | -47.13% | -28.78% | -4.18% | 2051.36% | -67.39% | Upgrade
|
| Net Cash Per Share | 1.64 | 4.36 | 8.02 | 11.31 | 14.51 | 0.60 | Upgrade
|
| Filing Date Shares Outstanding | 8.65 | 8.11 | 8.22 | 8.36 | 8.33 | 7.65 | Upgrade
|
| Total Common Shares Outstanding | 8.65 | 8.1 | 8.27 | 8.36 | 8.31 | 7.65 | Upgrade
|
| Working Capital | 10.77 | 33.01 | 65.3 | 94.55 | 121.99 | 3.81 | Upgrade
|
| Book Value Per Share | 0.57 | 3.37 | 7.21 | 10.65 | 14.04 | -7.77 | Upgrade
|
| Tangible Book Value | 4.91 | 27.31 | 59.58 | 88.98 | 116.57 | -59.46 | Upgrade
|
| Tangible Book Value Per Share | 0.57 | 3.37 | 7.21 | 10.65 | 14.04 | -7.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.